Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q3 FY2022 Earnings Presentation
31 slides from Apollo Hospitals Enterprise's earnings presentation, Feb 12, 2022
Slide 1: Exchange filing cover letter under Regulation 30
APOLLO HOSPITALS ENTERPRISE LIMITED At~lillo I HOSPITALS CIN: L85110TN1979PLC008035 TOUCHING LIVES l2I February 2022 The Secretary, The Secretary, The Manager Bombay Stock Exchange Ltd (BSE) National Stock Exchange, The National Stock Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Exchange,
Slide 2: Earnings Update Q3 FY 2022
EARNINGS UPDATE Q3 FY 2022 1
Slide 3: Disclaimer
DISCLAIMER • No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the
Slide 4: Key Highlights
Key Highlights HIGHLIGHTS CONSOLIDATED FINANCIAL STANDALONE FINANCIAL PERFORMANCE PERFORMANCE OPERATIONAL PARAMETERS - APOLLO 24/7 APOLLO HEALTH & LIFESTYLE LTD HOSPITALS & PHARMACIES 3
Slide 5: Highlights
HIGHLIGHTS i
Slide 6: Highlights: Financial Performance Q3 FY22
HIGHLIGHTS Q3 FY22 Consolidated Revenues of ` 36,389 mio (growth of 32% yoy). Q3 FY22 Consolidated EBITDA (Post Ind AS 116) of ` 5,870 mio. Financial New Hospitals (excl Proton) reported an EBITDA of ` 1,189 mio in Q3 FY22 as compared to an EBITDA of ` 645 mio in Q3 FY21. Performance Q3 FY22
Slide 7: Highlights: Capacity and Medical
HIGHLIGHTS 71 hospitals with total bed capacity of 10,033 beds as on December 31, 2021. 44 owned hospitals including JVs/ Subsidiaries and Associates with 8,660 beds. 11 Day care/ short surgical stay centres with 244 beds and 11 Cradles with 278 beds. Capacity 5 Managed hospitals with 851 be
Slide 8: COVID Testing and Treatment – YTD Dec21
COVID TESTING AND TREATMENT – YTD Dec21 ‘Project Stay I’ saw success with over 24,000 600+ 31,500 + room nights. Dedicated beds In -Patients 2,900+ Stay I Our effort in the Home care segment enabled us to move into 73,000 homes, (of which COVID care was at 22,000 homes) and provide medically sup
Slide 9: Consolidated Financial Performance
CONSOLIDATED FINANCIAL PERFORMANCE
Slide 10: Consolidated Financial Performance
CONSOLIDATED FINANCIAL PERFORMANCE TOTAL (` mio) Q3 FY 21 Q3 FY 22 yoy (%) YTD Dec 20 YTD Dec 21 yoy (%) Total Revenues 27,598 36,389 31.9% 76,921 111,162 44.5% EBITDA (Post Ind AS 116) 3,903 5,870 50.4% 7,256 17,219 137.3% margin (%) 14.1% 16.1% 199 bps 9.4% 15.5% 606 bps EBIT 2,653 4,380 65.1% 2,9
Slide 11: Consolidated Mature & New Breakup – Q3 FY22
CONSOLIDATED FINANCIAL PERFORMANCE MATURE & NEW BREAKUP – Q3 FY22 (` mio) Key Highlights Healthcare Healthcare Healthcare Serv Serv Serv Pharmacy HCS revenue grew by 41% in Q3FY22 Group Proton AHLL Consol Group Group Distribution* (New & (Mature) (Total) Others) Hospitals 29 14 1 44 Operating beds 5
Slide 12: Consolidated Mature & New Breakup – YTD Dec21
CONSOLIDATED FINANCIAL PERFORMANCE MATURE & NEW BREAKUP – YTD DEC21 (` mio) Healthcare Healthcare Healthcare Key Highlights Serv Serv Serv Pharmacy Group Proton AHLL Consol Group Group Distribution* HCS revenue grew by 77% in YTD Dec21 (New & (Mature) (Total) Others) Hospitals 29 14 1 44 Operating b
Slide 13: Standalone Financial Performance
STANDALONE FINANCIAL PERFORMANCE
Slide 14: Standalone Financial Performance
STANDALONE FINANCIAL PERFORMANCE (` mio) TOTAL Q3 FY 21 Q3 FY 22 yoy (%) YTD Dec 20 YTD Dec 21 yoy (%) Revenue 23,670 28,462 20.2% 67,430 86,641 28.5% Operative Expenses 13,932 16,467 18.2% 39,901 51,166 28.2% Employee Expenses 2,690 3,064 13.9% 9,821 9,445 -3.8% Administrative & Other Expenses 3,82
Slide 15: Standalone Mature & New Breakup – Q3 FY22
STANDALONE FINANCIAL PERFORMANCE MATURE & NEW BREAKUP – Q3 FY22 (` mio) Key Highlights Healthcare Healthcare Pharmacy Service New Services Standalone (Mature) Hospitals Proton (Total) Distribution* HCS revenue grew by 24% in Q3FY22 Hospitals 20 10 1 31 Operating beds 3,278 1,638 53 4,969 Occupancy 6
Slide 16: Standalone Mature & New Breakup – YTD Dec21
STANDALONE FINANCIAL PERFORMANCE MATURE & NEW BREAKUP –YTD DEC21 (` mio) Healthcare Healthcare New Pharmacy Key Highlights Service Proton Services Standalone Hospitals Distribution* (Mature) (Total) Hospitals 20 10 1 31 HCS revenue grew by 57% in YTD Operating beds 3,278 1,638 53 4,969 Dec21 Occupan
Slide 17: Standalone Segment Reporting
STANDALONE FINANCIAL PERFORMANCE SEGMENT REPORTING (` mio) Q3 FY 21 Q3 FY 22 yoy (%) YTD Dec 20 YTD Dec 21 yoy (%) Revenues from each segment Healthcare Services* 12,407 15,388 24.0% 29,858 46,776 56.7% Stand-alone Pharmacy 0 0 22,698 0 -100.0% Pharmacy Distribution** 11,263 13,074 14,875 39,865 Tot
Slide 18: Operational Parameters - Hospitals & Pharmacies
OPERATIONAL PARAMETERS - HOSPITALS & PHARMACIES
Slide 19: Operational Parameters - Hospitals
OPERATIONAL PARAMETERS - HOSPITALS (` mio) Tamilnadu Region AP, Telengana Region Karnataka Region Significant Subs/JVs/associates Total (6) Others (4) (Chennai & others) (1) (Hyderabad & others) (2) (Bangalore & others) (3) (5) YTD Dec YTD Dec YTD Dec YTD Dec YTD Dec YTD Dec YTD Dec YTD Dec YTD Dec
Slide 20: Pharmacy Distribution
PHARMACY DISTRIBUTION (` mio) Pharmacy Distribution Q3 FY 21 Q3 FY 22 yoy (%) YTD Dec 20 YTD Dec 21 yoy (%) Revenue 11,263 13,074 16.1% 37,573 39,865 6.1% EBITDA (Post Ind AS 116)** 745 964 29.4% 3,121 3,061 -1.9% margin (%) 6.6% 7.4% 76 bps 8.3% 7.7% -63 bps *Pharmacy Distribution from 1st Sep 2020
Slide 21: Apollo 24/7
APOLLO 24/7 i
Slide 22: Apollo 24/7 – India's Largest Omni-Channel Healthcare Platform
APOLLO 24X7 – INDIA’S LARGEST OMNI-CHANNEL HEALTHCARE PLATFORM LEVERAGING PHYSICAL NETWORK Distinctive digital 5 ecosystem … 4 Condition 6 management Digital services Online Health diagnostic predictor 3 booking 7 Well-being Part of Virtual doctor companion consultation Apollo 24/7 2 Online 8 Health
Slide 23: Distinctive digital ecosystem coupled with physical network
Distinctive digital ecosystem… … coupled with adequate network and capabilities Cumulative upto 31st Dec 2021 Physical network & capabilities ~11 Lakh+ 1 2 3 Doctors across 3mm+ Annual Online Consults Diagnostic centers Hospitals & clinics chronic patients ~12.5Mn completed 4 5 Registrations Leverag
Slide 24: Apollo HealthCo
APOLLO HEALTHCO Reorganization through Slump Sale AHEL (Listed) • Apollo 24/7 represents Apollo Group’s transformational journey to creating “India’s Largest Omnichannel Digital Healthcare Platform” that: Backend combines the strengths of Apollo Group’s offline healthcare Healthcare Pharmacy + lea
Slide 25: Apollo Health & Lifestyle Ltd
APOLLO HEALTH & LIFESTYLE LTD
Slide 26: AHLL – Q3 FY22
AHLL – Q3 FY22 (` mio) Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) Key Highlights Network 236 1109 24 70 85 8 15 11 Footfalls/Day* 4284 12639 416 182 1289 45 21 75 AHLL reported Gross ARPP (Rs.)* 1417 829 3259 6392 1525 99345 38091 102441 • EBITDA of ` 495 mio as compared
Slide 27: AHLL – YTD Dec 21
AHLL – YTD DEC 21 (` mio) Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) Key Highlights Network 236 1109 24 70 85 8 15 11 Footfalls/Day* 6792 12929 381 144 1183 43 18 68 AHLL reported Gross ARPP (Rs.)* 1254 671 2924 6428 1509 101428 37995 104185 • EBITDA of ` 1,596 mio as co
Slide 28: Strategic Portfolio Approach for AHLL
STRATEGIC PORTFOLIO APPROACH FOR AHLL Accelerated Growth Continued Growth as per plan Sustainability and Asset Light Growth Aim for market leadership Established player Sustained growth with synergies to the Focus on enhancing market share across India Focus on improving capabilities and opportunist
Slide 29: Appendix 1: Ind AS 116 Impact on P&L and Balance Sheet
APPENDIX 1 : IND AS - 116 IMPACT ON P&L AND BALANCE SHEET – YTD DEC 21 (` mio) AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Revenue - Right of use Revenue Right of use Asset as of 5,816 Asset as of 9,752 Other 662 Other
Slide 30: Appendix 2: Basis of Consolidation
APPENDIX 2 : BASIS OF CONSOLIDATION AHEL Standalone Location Description AHEL Ownership AHEL Chennai Main Chennai Hospital Subsidiaries Location Description Ownership ACI - Chennai Chennai Hospital Samudra Healthcare Enterprises Ltd. Kakinada Hospital 100.00% Tondiarpet - Chennai Chennai Hospital Ap
Slide 31: Thank You
THANK YOU 30
Apollo Hospitals Enterprise — Q3 FY2022 Earnings Presentation on 6ix